Aspire Biopharma Holdings, Inc. Common Stock (NASDAQ: ASBP) last traded at $7.97, up 1.92% on the session. The quote above updates while this page is open; the figures below are drawn from Aspire Biopharma Holdings, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aspire Biopharma Holdings, Inc. Common Stock trades on NASDAQ under the ticker ASBP. Its market capitalisation is $11.18 million.
Valuation measures for Aspire Biopharma Holdings, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $11.18M |
|---|---|
| Enterprise value | $794.0K |
| Price / sales | 1802.38 |
| Price / book | 0.95 |
| Beta | 5.34 |
Trailing-twelve-month figures tagged in Aspire Biopharma Holdings, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $6.2K |
|---|---|
| Net income (TTM) | -$11.05M |
| Gross margin | -1.87% |
| Operating margin | -118015.35% |
| Return on equity | -93.97% |
| Cash | $12.17M |
Range and volume for ASBP over the past 52 weeks.
| 52-week high | $23.80 |
|---|---|
| 52-week low | $0.110 |
| Volume | 30.4K |
| Average volume | 294.4K |
| Previous close | $7.82 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.